Clinical Trial

NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases

Study acronym: NIVATS-2
Completed
View on ClinicalTrials.gov →
Summary
The main objective of this study is to compare two independent groups of patients requiring lung biopsy for undetermined interstitial lung disease (ILD) in terms of diagnostic confidence as determined by histologists.
Protocol Amendment History 3 changes
critical Trial completed 2026-07-19
notable Primary completion moved earlier: 2026-11-24 -> 2026-06-29 2026-07-19
minor Completion moved earlier: 2026-11-24 -> 2026-06-29 2026-07-19
Trial Details
NCT Number NCT05722340
Lead Sponsor University Hospital, Montpellier
Collaborators: Grace Asso (Groupe francophone de Réhabilitation Améliorée après Chirurgie)
Conditions Lung Diseases, Interstitial
Enrollment 24 participants
Start Date 2023-05-24
Primary Completion 2026-06-29 (estimated)
Study Completion 2026-06-29 (estimated)
Updated on ClinicalTrials.gov 2026-07-17